U.S. Markets closed

aap Implantate AG (AAQ1.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
3.70000.0000 (0.00%)
At close: 05:36PM CET

aap Implantate AG

Lorenzweg 5
Berlin 12099
49 30 75019 0

IndustryMedical Devices
Full Time Employees111

Key Executives

NameTitlePayExercisedYear Born
Mr. Rubino Di GirolamoChairman of the Management Board & CEO205kN/A1962
Mr. Marek HahnMember of the Management Board & CFO279kN/A1975
Ms. Agnieszka MierzejewskaMember of Management Board & COON/AN/A1983
Fabian FrankeHead of Investor RelationsN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany, the United States, and internationally. It offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

Corporate Governance

aap Implantate AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.